Clinical Trials Browser

Phase 3 × Neoplasm Metastasis × Methylphenidate × Clear all

NCT03525873 2025-10-20

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Phase 3 Active not recruiting

Neoplasm Metastasis, Recurrence